Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 14 at 2:00 PM EDT

Register Free →
logo
Get CLEATUS

Research Project Cooperative Agreements in Aging and/or Alzheimer's disease (AD) and Alzheimer's disease-related dementias (ADRD) Research

Active
Grant

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The National Institute on Aging within the Department of Health and Human Services is forecasting a Notice of Funding Opportunity for research project cooperative agreements. The initiative seeks new, renewal, and competing revision applications focused on the health and well-being of older adults, encompassing genetic, biological, clinical, and social research. A significant priority is placed on Alzheimer's disease and Alzheimer's disease-related dementias, including Frontotemporal dementia and Lewy body dementias, to better understand the aging process and extend healthy life years. These agreements will utilize the U01 activity code, which necessitates substantial programmatic involvement such as the establishment of milestone plans, the formation of an External Scientific Panel, and the development of coordinating committees. While applications are not currently being accepted, prospective applicants are encouraged to contact NIA program staff to ensure their proposed research aligns with programmatic priorities before the official solicitation is published.

General Info

NIA seeks U01 cooperative research on aging, Alzheimer's, and related dementias with collaborative management.

Agency

Department Of Health And Human Services → National Institutes Of Health

NAICS

541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

Place of Performance

Not specified

Set-Aside

NONE

Documents

0

No documents available

Documents will appear here when they are available.

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

Posted

forecast

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → National Institutes Of Health
Contacts1 person available
OfficeUSA
Organization / AgencyDepartment Of Health And Human Services → National Institutes Of Health
Office AddressUSA
Contacts
NIA Scientific Contact
contact@example.gov

Full Description

Show more

The National Institute on Aging (NIA) intends to publish a Notice of Funding Opportunity (NOFO) to solicit new, renewal, and competing revision applications, and their resubmissions, for research project cooperative agreements. The proposed research must be relevant to the mission of NIA. Areas of research that fall within NIA’s mission include: genetic, biological, neuroscientific, preclinical, clinical, behavioral, social, psychological, and economic research on aging and the health and well-being of older people.  This includes research to understand the nature of aging and the aging process, research on diseases and conditions associated with aging, and other special problems and needs associated with growing older, in order to extend the healthy, active years of life. NIA places major emphasis on, and has substantial resources for, research on Alzheimer's disease (AD) and Alzheimer's disease-related dementias (ADRD). ADRDs include Frontotemporal dementia, vascular contributions to cognitive impairment and dementia, Lewy body dementias, and multiple etiology dementias based on similarities in clinical symptoms and brain pathologies between these and pathologic AD and/or clinical AD.

The NOFO intends to utilize the U01 activity code. The U01 activity code requires substantial programmatic involvement in order to execute the research. This includes, but is not limited to, the following: establishing milestone plans, access to various NIH resources, collaborative activities of a consortium, the development of working groups and/or coordinating committees, and the formation of an External Scientific Panel.

Applications are not being solicited at this time. This notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects.

Prospective applicants are strongly encouraged to contact NIA program staff prior to submitting an application to discuss the responsiveness of their proposed research to the NOFO and its relevance to NIA’s programmatic priorities.

Similar Contracts

Same NAICS industry code

NAICS: 541715
New
Federal
CHEERS MAA Open Period 1 - All Technical Areas, 10 U.S.C. 4001 Broad Agency Announcement (BAA)
Solicitation # FA238424S2334
Solicitation FA238424S2334, titled Open Period 1 - All Technical Areas, is a Broad Agency Announcement issued by the Air Force Research Laboratory Human Effectiveness Directorate and the United States Air Force School of Medicine. This effort is part of the Continuing Human Enabling, Enhancing, Restoring, and Sustaining (CHEERS) program and is authorized under 10 U.S.C 4001 and FAR 35.016. The program seeks research across all technical areas defined in the CHEERS Multiple Authority Announcement, with a total aggregate award value not to exceed 484.73 million dollars. The acquisition follows a two-step process, beginning with the submission of white papers due by September 30, 2027. Offerors may submit multiple white papers provided each presents a unique approach. Submissions that are assessed as meeting Air Force needs will be invited to submit full technical and cost proposals. The evaluation process is governed by the CHEERS MAA Industry Guide, and the government reserves the right to award some, all, or none of the proposals without negotiation, though it may negotiate with selected offerors. Contractors must comply with stringent security and regulatory requirements, including the National Industrial Security Program Operating Manual for classified information and DFARS standards for safeguarding covered defense information, supply chain risk, and counterfeit electronic part detection. Administrative requirements include the use of the Wide Area Workflow system for electronic invoicing and payment. All offerors must maintain current representations and certifications in the System for Award Management.
FA2384 USAF Afmc Afrl Pzl Afrl Rakh

POSTED

about 9 hours ago

DEADLINE

in 12 months
View Details
NAICS: 541715
New
Federal
CHEERS MAA Open Period 2 - All Technical Areas, 10 U.S.C. 4023 - Procurement for Experimental Purposes (ARA)
Solicitation # FA238424S2335
Solicitation FA238424S2335, titled Open Period 2 - All Technical Areas, is issued by the Air Force Research Laboratory and the United States Air Force School of Medicine under the Continuing Human Enabling, Enhancing, Restoring, and Sustaining (CHEERS) program. Authorized by 10 U.S.C. 4023 for experimental and test purposes, the program seeks research efforts across all technical areas defined in the CHEERS Multiple Authority Announcement. The total value for multiple awards under this solicitation is not to exceed 499.87 million dollars. The procurement process follows a two-step approach, currently soliciting only white papers with a response deadline of September 30, 2027. Only offerors whose white papers are determined to meet Air Force needs will be invited to submit full technical and cost proposals. The contract emphasizes strict compliance with military standards for item identification and marking, specifically MIL-STD-130 and MIL-STD-129, with reporting handled through the Wide Area WorkFlow system. Evaluation includes a 10 percent price preference for HUBZone small business concerns. Security requirements are significant, involving access to classified information up to Top Secret and adherence to DFARS cybersecurity standards, including NIST SP 800-171. While specific deliverables and the period of performance are to be determined based on the proposed approach, the solicitation incorporates comprehensive FAR and DFARS clauses covering inspection, acceptance, and domestic trade preferences.
FA2384 USAF Afmc Afrl Pzl Afrl Rakh

POSTED

about 9 hours ago

DEADLINE

in 12 months
View Details
NAICS: 541715
New
Federal
Satellite Launch and End-of-Life Support Services
National Oceanic And Atmospheric Administration

POSTED

1 day ago

DEADLINE

in 17 days
View Details
NAICS: 541715
New
Federal
Geophysical Modeling (Gravity & Magnetics)
Attn: Ms S84 - Ocs

POSTED

1 day ago

DEADLINE

in 2 months
View Details
NAICS: 541715
New
Federal
Geodetic & Reference Frame Research
Attn: Ms S84 - Ocs

POSTED

1 day ago

DEADLINE

in 2 months
View Details
NAICS: 541715
New
Federal
Unmanned Underwater/Surface Vehicle (UUV/USV) Operations
Navfac Systems And Experimental Warfare Ctr

POSTED

1 day ago

DEADLINE

in 13 days
View Details
NAICS: 541715
New
Federal
Innovative Commercial Technology Provider
Dcso Philadelphia

POSTED

1 day ago

DEADLINE

in almost 5 years
View Details
NAICS: 541715
New
Federal
Advanced Combustion & Oxidizer Development
Naval Air Warfare Center

POSTED

1 day ago

DEADLINE

in 12 months
View Details
NAICS: 541715
New
Federal
Energetic Materials & Reactive Materials Research
Naval Air Warfare Center

POSTED

1 day ago

DEADLINE

in 12 months
View Details
NAICS: 541715
New
Federal
HERMES BAA CALL: Rotating Detonation Rocket Engine-Combined Cycle (RDRE-CC) Flight Demonstration
Solicitation # FA9300-20-S-0001-CALL-RDRE-CC
The Air Force Research Laboratory Rocket Propulsion Division is seeking innovative research and development to advance Rotating Detonation Rocket Engine-Combined Cycle propulsion systems from Technology Readiness Level 3 to TRL 6. The goal of this effort is to conduct a ground-launched, sounding-rocket-boosted flight demonstration to validate operational viability for future High-Speed Affordable Mass Munitions. The scope of work includes engine development, direct-connect and freejet testing, vehicle development, and a final flight demonstration, with an anticipated period of performance between 36 and 48 months. This is a full and open competition utilizing a two-step solicitation process. Interested parties must first submit a white paper by November 16, 2026, detailing their technical architecture, compliance with specific test objectives, and a rough order of magnitude cost. Only offerors with high technical merit will be invited to submit a full proposal. Due to the sensitive nature of the technology, detailed requirements are restricted to certified U.S. defense contractors with an active DD Form 2345 and JCP certification.
FA9300 Aftc Pzr

POSTED

1 day ago

DEADLINE

in about 2 months
View Details
NAICS: 541715
New
Federal
Commercial Solutions Opening (CSO)
Solicitation # SP4701-27-S-C001
The Defense Logistics Agency (DLA) has established a Commercial Solutions Opening (CSO) framework running from 2026 through October 1, 2031, to acquire innovative commercial technologies, products, and services. Operating under 10 U.S.C. 3458 and DFARS Subpart 212.70, the DLA will solicit Solution Briefs on a rolling basis in response to published Areas of Interest (AOIs) that describe specific capability gaps or technical challenges. All resulting awards must be fixed-price, and the government may utilize Other Transaction (OT) Agreements for prototype projects under 10 U.S.C. 4022 or FAR Part 12 procedures for commercial products and services. Successful prototype projects may lead to non-competitive follow-on production contracts. Interested offerors must submit an unclassified Solution Brief not exceeding eight pages, with an optional two-page narrative or five-slide executive summary. Submissions are evaluated based on technical feasibility, importance to agency programs, and viability, including cybersecurity compliance and alignment with federal policies. The process involves an initial conformance review and funding availability assessment, followed by technical evaluations by subject matter experts. Selected offerors may be invited to a pitch, requested to submit a full proposal, or moved directly to award negotiations. DLA provides no funding for the submission process, and all proposed pricing must remain valid for 180 days.
Dcso Philadelphia

POSTED

1 day ago

DEADLINE

in almost 5 years
View Details
NAICS: 541715
New
Federal
Synthetic Training Environment (STE) Virtual Software (VSW)
Solicitation # STE-VSW-26-0006
The Army Contracting Command - Aberdeen Proving Grounds Orlando Division, on behalf of the Capability Program Executive Simulation, Training, Test and Threat, is issuing a Call for Solutions for the Synthetic Training Environment Virtual Software project. The objective is to implement a modernized virtual software ecosystem that delivers a certifiable Table II virtual collective gate for mounted maneuver, a true combined arms environment, full mission command concurrency, and an open system architecture with published SDKs and APIs. The procurement is structured into five capability lots: Lot 1 for Common Core Software, Lot 2 for Simulation Application Software, Lot 3 for HIL Integration, Lot 4 for Training Management and AAR capabilities, and Lot 5 for Enterprise Integration Support. The total project value is estimated at approximately 250 million dollars. The acquisition process utilizes a down-select method based on mandatory technical readiness, schedule credibility, technical merit, and viability. For Lots 1, 3, and 5, the solution submission deadline is October 13, 2026, at 1000 EDT, with anticipated awards by November 20, 2026. Lot 2 and Lot 4 submissions are deferred. A critical organizational conflict of interest rule prohibits any entity performing on Lot 5 from participating in Lots 1, 2, or 4. Technical requirements emphasize the use of an unclassified CUI environment, FedRAMP High or DoD IL4/IL5 cloud authorizations, and the provision of Government Purpose Rights for connectors to ensure multi-vendor integration. The Lot 5 awardee is specifically responsible for providing the physical laboratory facility and network infrastructure in Orlando, Florida.
W6QK Acc-Apg-Orlando

POSTED

1 day ago

DEADLINE

in 11 days
View Details

More opportunities from Department Of Health And Human Services → National Institutes Of Health

Same awarding agency

NAICS: 541715
New
Grant
HIV Prevention and Alcohol (R61/R33 Clinical Trials Optional)The National Institutes of Health, under the Department of Health and Human Services, is offering a Phased Innovation Award to advance innovative HIV prevention interventions. This funding opportunity utilizes a two-stage R61/R33 structure to move research from initial development and feasibility testing to larger-scale efficacy and implementation studies. The initial R61 phase focuses on the development, refinement, and pilot testing of novel strategies to address critical scientific and operational questions, ensuring readiness for expanded evaluation across diverse populations. Upon the successful completion of R61 milestones, the R33 phase provides support for expanded testing of interventions and implementation strategies. These studies may evaluate the scalability, sustainability, and clinical management of HIV prevention interventions, specifically including integrated approaches that address alcohol use and related comorbidities. Interested parties can contact the HIV/AIDS and Alcohol Research Program for further information.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

1 day ago

DEADLINE

N/A
View Details
NAICS: 541715
New
Grant
Early to Definitive Clinical Trials (R61/R33 Clinical Trial Required)The National Institutes of Health is forecasting a Notice of Funding Opportunity to solicit applications for early to definitive clinical trials. This initiative seeks proposals testing a wide range of interventions, including drugs, devices, biologics, procedures, and behavioral or social interventions, provided they align with the research missions of the participating NIH Institutes, Centers, and Offices. The funding will utilize a bi-phasic, milestone-driven R61/R33 activity code with a maximum project period of seven years. The R61 phase focuses on planning activities, while the R33 phase supports the actual clinical trial. Although applications are not currently being accepted, this notice serves as an advance alert for investigators with expertise in trial design, implementation, and stakeholder engagement to begin developing collaborations and projects.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

4 days ago

DEADLINE

N/A
View Details
NAICS: 541715
Grant
Continuation of the Exceptional Longevity Data Management and Coordinating Center (EL DMCC) (U24 Clinical Trial Not Allowed)The National Institute on Aging intends to issue a single U24 cooperative agreement award to support the continued operation and expansion of the Exceptional Longevity Data Management and Coordinating Center. Serving as the central hub for human longevity translational research, the center integrates deeply phenotyped cohorts and multi-omics datasets to enable cross-cohort analyses and collaborative research. Key responsibilities include data harmonization, the implementation of common data standards, and the management of the ELITE Portal, which provides the research community with secure access to analytical tools and cloud-based computational workspaces. The upcoming funding opportunity will require the Coordinating Center to expand its capabilities in artificial intelligence, machine learning, and the integration of diverse datasets across different species. Future objectives include the development of curated target knowledgebases for therapeutic targets, the enhancement of portal interoperability according to FAIR data principles, and the strengthening of community engagement through specialized training and workshops. This notice serves as a forecast to allow potential applicants to establish collaborations before the official solicitation is released.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

9 days ago

DEADLINE

N/A
View Details
NAICS: 541714
Grant
Immune Drivers of Autoimmune DiseaseThe National Institute of Allergy and Infectious Diseases seeks to support the Immune Drivers of Autoimmune Disease network to investigate the triggers and early mechanisms of autoimmunity in humans. The primary goal is to develop tools for risk prediction and staging, identify pre-clinical immune mechanisms, and utilize artificial intelligence and big data to prevent autoimmune diseases. This initiative emphasizes the creation of preclinical cohorts and the use of remote recruitment and sampling to advance medical research. The network will be managed by a Coordinating Center responsible for data harmonization, sample sharing, and the administration of an Infrastructure Opportunity Fund for collaborative research projects. This forecast, issued by the National Institutes of Health under the Department of Health and Human Services, establishes a framework for shared infrastructure and steering committee oversight to identify common pathways and prevention opportunities.
Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

9 days ago

DEADLINE

N/A
View Details
NAICS: 513130
Grant
NLM Grants for Scholarly Works in Biomedicine and Health (G13 Clinical Trial Not Allowed)The National Institutes of Health, through the Department of Health and Human Services, is soliciting applications for the NLM Grants for Scholarly Works in Biomedicine and Health program. This initiative provides funding for the creation of book-length manuscripts and other integrative scholarly works, such as critical reviews and analytical syntheses, designed to benefit U.S. health professionals, scientists, and public health practitioners. The primary goal is to organize and disseminate biomedical and health-related knowledge to improve research, education, and clinical practice. This opportunity is listed as a forecast with a posted date of September 24, 2026. It specifically prohibits the use of clinical trials. Interested parties can contact the NLM Extramural Programs office for further information regarding the application process and program requirements.
Book Publishers

POSTED

9 days ago

DEADLINE

N/A
View Details
NAICS: 541714
Grant
Partnerships for Advancing Development of Diagnostics for Infectious DiseasesThe National Institute of Allergy and Infectious Diseases, under the National Institutes of Health, is seeking to establish partnerships between academic or small business investigators and industrial partners to advance the translational development of diagnostic tests for infectious diseases. This initiative focuses on moving diagnostics that have already demonstrated proof-of-concept through the commercialization process by aligning researchers with experienced industry partners to de-risk development and ensure products are fit for purpose. The program will be supported by a science advisory board and NIAID oversight, incorporating annual meetings and workshops to facilitate collaboration and knowledge exchange. This effort is authorized under the Public Health Service Act and federal regulations to ensure that promising diagnostic technologies are successfully translated into tools for treating and preventing infectious diseases.
Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

9 days ago

DEADLINE

N/A
View Details
NAICS: 541715
Grant
LeverAging StraTegies to Maximize ImpLementation and Effectiveness for HIV (LAST MILE)The National Institute of Allergy and Infectious Diseases, under the Department of Health and Human Services, is forecasting the LeverAging StraTegies to Maximize ImpLementation and Effectiveness for HIV (LAST MILE) program. This initiative aims to bridge the gap between traditional clinical trial findings and real-world application by supporting collaborations on effectiveness trials, pragmatic trials, and hybrid effectiveness-implementation studies. The program focuses on the prevention and treatment of HIV, including associated coinfections and comorbidities, across all age groups and various points of care. The goal of the program is to advance cross-cutting research in epidemiology, implementation science, and clinical, behavioral, and social sciences. This effort aligns with the broader NIH mission to implement research advances in HIV/AIDS. The opportunity is authorized under the Public Health Service Act and relevant federal regulations, with administrative oversight provided by the Division of AIDS Epidemiology Branch.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

9 days ago

DEADLINE

N/A
View Details
NAICS: 541715
Grant
Collaborative Centers in Children’s Environmental Health Research and Translation (P2C Clinical Trial Optional)The National Institutes of Health, under the Department of Health and Human Services, is seeking applications to establish a national network of Children's Environmental Health Research Translation Centers. These centers are designed to protect and improve children's health by developing scientific questions and public health interventions focused on translational research. A primary objective is to move evidence-informed biomedical findings into practical application for the wider community while mentoring a new generation of investigators in the field. Beyond research and translation, the program will function as a national resource to coordinate responses to emerging environmental exposures that impact children. The initiative emphasizes the creation of actionable strategies to prevent harm and ensure a healthy future for children through collaborative efforts within the environmental health community.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

9 days ago

DEADLINE

N/A
View Details
NAICS: 541714
Grant
The Role of the Innate Immune System in the Pathogenesis of Type 1 DiabetesThe National Institute of Allergy and Infectious Diseases, under the Department of Health and Human Services, is forecasting a grant opportunity to investigate the role of the innate immune system in the initiation of Type 1 Diabetes. Funded by the Special Statutory Funding Program for Type 1 Diabetes Research, this initiative seeks to identify genetic and environmental causes of the disease by examining how innate immune components interact with beta cells and pancreatic tissues. The program emphasizes the use of new approach methodologies to determine the timing and impact of environmental triggers that activate these immune pathways. The primary objective is to improve the early identification of high-risk individuals and develop future prevention and therapeutic strategies. This effort is conducted under the authority of the Public Health Service Act and relevant federal regulations. Interested parties can contact the RISP-T1D point of contact for further information regarding this forecast.
Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

9 days ago

DEADLINE

N/A
View Details
NAICS: 541715
Grant
Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)The National Institute of Neurological Disorders and Stroke (NINDS) is seeking to support scientific research using data from intermediate-size patient population expanded access protocols for Amyotrophic Lateral Sclerosis (ALS). To be eligible, protocols must provide access to an investigational drug or biological product for individuals with ALS and generate data that supports research into the prevention, diagnosis, mitigation, treatment, or cure of the disease. Research goals may include analyzing the effects of products on biomarkers, target engagement, safety and outcome information such as survival and hospitalization, or general patient experience data. This opportunity is currently listed as a forecast by the National Institutes of Health under the Department of Health and Human Services, and applications are not being solicited at this time. The notice serves as a preliminary announcement to allow potential applicants sufficient time to develop responsive projects. Interested parties can contact the ALS Program for further information.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

10 days ago

DEADLINE

N/A
View Details
NAICS: 541715
Grant
Research to Improve Rigor, Replicability, and Reproducibility in Biomedical and Behavioral SciencesThe National Institute of Neurological Disorders and Stroke, in collaboration with other NIH entities, is forecasting support for research projects aimed at enhancing biomedical and behavioral rigor, replicability, and reproducibility. Key areas of interest include assessing the scientific impact of these improvements, creating frameworks for selecting high-value replication studies, and measuring the robustness and generalizability of research findings to drive scientific innovation. This notice serves as a forecast to allow potential applicants to establish collaborations and develop responsive projects, as formal applications are not currently being solicited. Interested parties can contact the NINDS Office of Research Quality for further information.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

11 days ago

DEADLINE

N/A
View Details
NAICS: 541715
Grant
Advancing Real-World Effectiveness Evidence for Rapid-Acting Psychotropic Interventional Drugs (RAPIDs)The National Institutes of Health, through the National Institute of Mental Health, is issuing a forecast for a Notice of Funding Opportunity titled Advancing Real-World Effectiveness Evidence for Rapid-Acting Psychotropic Interventional Drugs (RAPIDs). This initiative aims to establish a research network to evaluate the clinical effectiveness, safety, and durability of rapid-acting treatments such as ketamine, esketamine, and psilocybin for individuals with serious mental illnesses. The primary objective is to generate actionable real-world evidence to determine how these interventions can be safely and sustainably integrated into routine clinical practice across diverse patient populations and healthcare settings. By addressing current gaps in knowledge regarding implementation and long-term benefits, the project seeks to inform future healthcare delivery strategies for emerging psychotropic treatments.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

17 days ago

DEADLINE

N/A
View Details

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS